Contributing editor, Condensates.com
|Published||March 4, 2020|
Good news for condensates scientists: The NIH last week announced an interesting new funding opportunity for research on biomolecular condensates.
The NIH, via the National Institute on Drug Abuse, has committed up to $1.2M for research beginning no earlier than March 2021 by up to 6 awardees. This funding is intended to help researchers explore the role of biomolecular condensates in HIV infection and disease, potentially in the context of substance abuse. Here’s the agency’s overview of the initiative’s aim:
To support research projects exploring the roles of biomolecular condensates (BMCs) and their regulators in processes relevant to HIV/SIV infection, replication, latency, or pathogenesis in the context of substance use disorders. These processes could include studies exploring BMC involvement in HIV infection, HIV replication (including viral gene expression), HIV latency formation or maintenance (including chromatin structure), or HIV pathogenesis (including neurodegenerative processes). Studies could also include investigation of roles for BMCs or their regulators on host cell functions in the context of HIV infection, antiretroviral therapy, and/or exposure to addictive substances.
For researchers interested in pursuing this opportunity, letters of intent are due on June 20 of this year and applications are due on July 20. For more details, check out the full request for applications here.